Difficulty: Medium
Average Score: 64%
Practice
Although children with Wilms tumor have a favorable prognosis, there are some adverse prognostic factors in children with Wilms tumor EXCEPT
Correct answer
D
Rationale
In pediatric oncology, understanding prognostic factors in Wilms tumor is crucial for providing optimal care. In this context, the correct answer, option D, "young age at diagnosis," is the exception among the adverse prognostic factors.
Children diagnosed at a young age with Wilms tumor typically have a more favorable prognosis compared to older children. This is due to the fact that younger children tend to respond better to treatment and have a higher survival rate.
Options A, B, and C are adverse prognostic factors in children with Wilms tumor. Large tumors (option A) can indicate a more advanced stage of the disease, making treatment more challenging. Anaplastic histology (option B) is associated with a more aggressive form of Wilms tumor, leading to a poorer prognosis. Loss of heterozygosity at chromosome 1p and 16q (option C) is a genetic abnormality that can also indicate a higher risk of disease progression and worse outcomes.
Educationally, recognizing these prognostic factors is essential for healthcare professionals caring for pediatric oncology patients. Understanding these factors helps in treatment planning, monitoring patient progress, and providing families with accurate prognostic information. It also underscores the importance of personalized and evidence-based care in pediatric oncology practice.
Children diagnosed at a young age with Wilms tumor typically have a more favorable prognosis compared to older children. This is due to the fact that younger children tend to respond better to treatment and have a higher survival rate.
Options A, B, and C are adverse prognostic factors in children with Wilms tumor. Large tumors (option A) can indicate a more advanced stage of the disease, making treatment more challenging. Anaplastic histology (option B) is associated with a more aggressive form of Wilms tumor, leading to a poorer prognosis. Loss of heterozygosity at chromosome 1p and 16q (option C) is a genetic abnormality that can also indicate a higher risk of disease progression and worse outcomes.
Educationally, recognizing these prognostic factors is essential for healthcare professionals caring for pediatric oncology patients. Understanding these factors helps in treatment planning, monitoring patient progress, and providing families with accurate prognostic information. It also underscores the importance of personalized and evidence-based care in pediatric oncology practice.